Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-037005
Filing Date
2025-07-31
Accepted
2025-07-31 16:10:44
Documents
56
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20250630.htm   iXBRL 10-Q 903177
2 EX-31.1 cort63025ex311.htm EX-31.1 9522
3 EX-31.2 cort63025ex312.htm EX-31.2 9603
4 EX-32.1 cort63025ex321.htm EX-32.1 5245
5 EX-32.2 cort63025ex322.htm EX-32.2 5171
  Complete submission text file 0001628280-25-037005.txt   4457656

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20250630.xsd EX-101.SCH 28551
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20250630_cal.xml EX-101.CAL 67045
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20250630_def.xml EX-101.DEF 82323
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20250630_lab.xml EX-101.LAB 440003
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20250630_pre.xml EX-101.PRE 275131
58 EXTRACTED XBRL INSTANCE DOCUMENT cort-20250630_htm.xml XML 489630
Mailing Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065
Business Address 101 REDWOOD SHORES PARKWAY REDWOOD CITY CA 94065 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

EIN.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 251171778
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)